NCT00324064

Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Children's Mercy Hospital Kansas City · Academic / Other
• Sex: All
• Age: 5 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Specific Aim 1 Healthy male and female subjects and growth hormone (GH) deficient subjects display sexually dimorphic GH responses to GHRH administration Specific Aim 2 GH responses to GHRH in both healthy controls and in GH deficient patients correlate with expression and activity of the stimulatory G proteins, G alpha q and G alpha S. G protein levels correlate with gonadal steroid levels. Specific Aim 3 Sexually dimorphic GH responses to GHRH are enhanced in Tanner Stage V compared to Tanner Stage 1 individuals

Detailed description

Growth hormone deficiency affects disproportionately more males than females. Although ascertainment bias plays a role in this sexual dimorphism, no plausible mechanism to fully explain this difference has been proposed. This investigator initiated study will provide currently unavailable data on sexual/age differences in response to GH stimulation testing. Data obtained from the study may provide a basis for developing appropriate normal ranges for adult GH testing, may provide a plausible mechanism for the enhanced hormone responsiveness observed in females, and may provide data on when the sexual differences to GH stimulation may develop. The objectives of this study are to: 1. Confirm the sexual dimorphism in growth hormone responses for adult growth hormone testing in healthy male and female subjects 2. Correlate peak Growth Hormone Releasing Hormone (GHRH)/arginine induced growth hormone responses with G protein levels in healthy subjects and in patients with a history of childhood GH deficiency 3. Determine whether sexual dimorphism is acquired during puberty

Conditions

• Growth Hormone Deficiency

Interventions

Type	Name	Description
PROCEDURE	GHRH/arginine stimulation testing	GHRH(Geref) 1mcg/kg IVP followed by Arginine 10% solution 0.5mg/kg (maximum of 30 Gm) infused over 30 minutes. Labs drawn 6 times over 2 hours.

Timeline

• Start date: 2007-07-01
• Primary completion: 2009-07-01
• Completion: 2009-07-01
• First posted: 2006-05-10
• Last updated: 2010-03-05

Locations

1 site across 1 country: United States